Literature DB >> 16793120

The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients.

Donald F Brophy1, Erika J Martin, Sheryl L Carr, Barry Kirschbaum, Marcus E Carr.   

Abstract

INTRODUCTION: Uremic bleeding frequently occurs in dialysis patients. Although its mechanism is not well characterized, acquired platelet dysfunction has been implicated in its pathogenesis. Skin bleeding time has been used to characterize platelet dysfunction in this population. However, the bleeding time is prone to error. The goal of this study was to compare the bleeding time to the novel platelet function parameters platelet contractile force and clot elastic modulus as well as platelet aggregation studies in controls and patients receiving maintenance hemodialysis.
MATERIALS AND METHODS: Forty-five subjects completed this study (25 controls, 20 dialysis). All subjects had the Ivy skin bleeding time procedure performed, as well as the collection of whole blood samples for the determination of platelet contractile force, clot elastic modulus, % von Willebrand Factor antigen, and platelet aggregation studies. Pearson's correlation determined the relationships between skin bleeding time and platelet function and clot structure parameters and markers of renal dysfunction.
RESULTS: Bleeding time was significantly prolonged in the dialysis group relative to controls. The platelet function parameters were not significantly different between groups. There was a significant relationship between bleeding time and creatinine concentration, however, no relationship existed between bleeding time and platelet function parameters.
CONCLUSIONS: Skin bleeding time poorly correlates with measurements of platelet function. There were no significant differences noted in platelet function between the groups despite the prolongations in bleeding time in the dialysis group. These data may suggest that the bleeding time reflects perturbations in platelet adhesion or secretion, and not aggregation. Further study is needed to characterize platelet function in dialysis patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793120     DOI: 10.1016/j.thromres.2006.02.013

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  Differences in coagulation between hemodialysis and peritoneal dialysis.

Authors:  Donald F Brophy; Daniel E Carl; Bassem M Mohammed; Jingmei Song; Erika J Martin; Jessica L Bostic; Todd W B Gehr
Journal:  Perit Dial Int       Date:  2013-12-01       Impact factor: 1.756

2.  Platelet aggregometry cannot identify uremic platelet dysfunction in heart failure patients prior to cardiac surgery.

Authors:  Josh Showalter; Nghia D Nguyen; Samer Baba; Chi Hyun Lee; Jing Ning; Kimberly Klein; M Amer Wahed; Ashok Tholpady
Journal:  J Clin Lab Anal       Date:  2016-10-31       Impact factor: 2.352

3.  Therapeutic management in patients with renal failure who experience an acute coronary syndrome.

Authors:  Héloise Cardinal; Peter Bogaty; Francois Madore; Luce Boyer; Lawrence Joseph; James M Brophy
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 8.237

4.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

Review 5.  Mechanobiology of platelets: techniques to study the role of fluid flow and platelet retraction forces at the micro- and nano-scale.

Authors:  Shirin Feghhi; Nathan J Sniadecki
Journal:  Int J Mol Sci       Date:  2011-12-07       Impact factor: 5.923

6.  Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.

Authors:  Yi-Hao Yen; Jin-Bor Chen; Ben-Chung Cheng; Jung-Fu Chen; Kuo-Chin Chang; Po-Lin Tseng; Cheng-Kun Wu; Ming-Chao Tsai; Ming-Tsung Lin; Tsung-Hui Hu
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

7.  Whole blood platelet aggregation and release reaction testing in uremic patients.

Authors:  Jay Zeck; Jason Schallheim; Susie Q Lew; Louis DePalma
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.